• About Us
  • Team
  • News
  • Contact
  • About Us
  • Team
  • News
  • Contact

Archives

Author Archive for: "Daniel Bloomfield, M.D."
Home » Archives for Daniel Bloomfield, M.D.
0
By Daniel Bloomfield, M.D.
In News
Posted October 2, 2018

Silvia Priori, M.D., Ph.D. Delivers the William Harvey Lecture on Basic Science

CAMBRIDGE, MASS. – [October 2, 2018] – The European Society of Cardiology Congress holds four specialized lectures each year and selects four renowned scientists who are seen by their peers as [...]

READ MORE
0
By Daniel Bloomfield, M.D.
In News
Posted September 20, 2018

Cardurion Pharmaceuticals Announces Initiation of Phase 1 Study of CRD-733, a PDE-9 Inhibitor in Development for the Treatment of Heart Failure

CAMBRIDGE, MASS. – [September 20, 2018] – Cardurion Pharmaceuticals, a biotechnology company focused on the development of novel, next-generation therapeutics for the treatment of cardiovascular [...]

READ MORE
0
By Daniel Bloomfield, M.D.
In News
Posted August 16, 2018

Cardurion Pharmaceuticals Appoints Jeb Keiper to Its Board of Directors

CAMBRIDGE, MASS. – [August 16, 2018] – Cardurion Pharmaceuticals, a biotechnology company focused on the development of novel, next-generation therapeutics for the treatment of cardiovascular [...]

READ MORE
0
By Daniel Bloomfield, M.D.
In News
Posted July 24, 2018

Cardurion Pharmaceuticals Appoints Rebecca Frey as Chief Operating Officer

CAMBRIDGE, MASS. – [July 24, 2018] – Cardurion Pharmaceuticals, a biotechnology company focused on the development of novel, next-generation therapeutics for the treatment of cardiovascular [...]

READ MORE
0
By Daniel Bloomfield, M.D.
In News
Posted June 26, 2018

Cardurion Pharmaceuticals Announces Formation of Scientific and Clinical Advisory Board

CAMBRIDGE, MASS. – [June 26, 2018] – Cardurion Pharmaceuticals, a biotechnology company focused on the development of novel, next-generation therapeutics for the treatment of cardiovascular [...]

READ MORE
1
By Daniel Bloomfield, M.D.
In News
Posted April 16, 2018

Cardurion Pharmaceuticals Licenses Clinical Stage Heart Failure Candidate from Astellas

Company expanding pipeline of novel treatments for cardiovascular disease CAMBRIDGE, MASS. – [April 16, 2018] – Cardurion Pharmaceuticals, a biotechnology company focused on the development of [...]

READ MORE
2
By Daniel Bloomfield, M.D.
In News
Posted August 2, 2017

Takeda and Cardurion Pharmaceuticals Launch Cardiovascular Development Partnership

Collaboration to develop novel, next-generation therapeutics to treat heart disease Osaka, Japan and Cambridge, Mass., – 2 August 2017 – Takeda Pharmaceutical Company Limited (TSE: 4502) and [...]

READ MORE
Navigation
  • About Us
  • Team
  • News
  • Contact
Contact Us

Cardurion Pharmaceuticals
Email: info@cardurion.com

Proudly Built By

Bellwether Digital